{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:47:26Z","timestamp":1780447646563,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271376"],"award-info":[{"award-number":["32271376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Project of Guangzhou, China","award":["2023B03J1353"],"award-info":[{"award-number":["2023B03J1353"]}]},{"name":"Clinical Characteristic Technology Project of Guangzhou Municipal Health Commission, China","award":["2023P-TS28"],"award-info":[{"award-number":["2023P-TS28"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation, China","award":["2025A1515011285"],"award-info":[{"award-number":["2025A1515011285"]}]},{"name":"\"Guangdong Special Support Plan\" Provincial Health Commission (Health Talent) Project, China","award":["0720240108"],"award-info":[{"award-number":["0720240108"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03840-x","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T11:36:24Z","timestamp":1764070584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeted suppression of CCR7\/NF-\u03baB signaling by apoptotic body-inspired colchicine nanovesicles halts atherosclerotic progression"],"prefix":"10.1186","volume":"23","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Shu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Bing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Na","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Guo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Tian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"3","key":"3840_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341\u201355.","journal-title":"Cell"},{"issue":"7347","key":"3840_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature (London). 2011;473(7347):317\u201325. https:\/\/doi.org\/10.1038\/nature10146.","journal-title":"Nature (London)"},{"issue":"5","key":"3840_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MOL.0000000000000440","volume":"28","author":"T Quillard","year":"2017","unstructured":"Quillard T, Franck G, Mawson T, Folco E, Libby P. Mechanisms of erosion of atherosclerotic plaques. Curr Opin Lipidol. 2017;28(5):434\u201341.","journal-title":"Curr Opin Lipidol"},{"key":"3840_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2019.10.043","volume":"316","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zhang Y, Dai L, Wang Q, Xue L, Su Z, et al. An apoptotic body-biomimic liposome in situ upregulates anti-inflammatory macrophages for stabilization of atherosclerotic plaques. J Control Release. 2019;316:236\u201349. https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.043.","journal-title":"J Control Release"},{"issue":"6917","key":"3840_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868\u201374.","journal-title":"Nature"},{"issue":"4","key":"3840_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101788","volume":"11","author":"Y Li","year":"2022","unstructured":"Li Y, Che J, Chang L, Guo M, Bao X, Mu D, et al. Cd47- and integrin alpha4\/beta1-comodified-macrophage-membrane-coated nanoparticles enable delivery of colchicine to atherosclerotic plaque. Adv Healthc Mater. 2022;11(4):e2101788.","journal-title":"Adv Healthc Mater"},{"issue":"4","key":"3840_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","volume":"118","author":"I Tabas","year":"2016","unstructured":"Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118(4):653\u201367. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306256.","journal-title":"Circ Res"},{"issue":"7855","key":"3840_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524\u201333.","journal-title":"Nature"},{"issue":"4","key":"3840_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","volume":"19","author":"W Chen","year":"2022","unstructured":"Chen W, Schilperoort M, Cao Y, Shi J, Tabas I, Tao W. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat Rev Cardiol. 2022;19(4):228\u201349.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"3840_CR10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41565-024-01687-1","volume":"19","author":"Z He","year":"2024","unstructured":"He Z, Chen W, Hu K, Luo Y, Zeng W, He X, et al. Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment. Nat Nanotechnol. 2024;19(9):1386\u201398.","journal-title":"Nat Nanotechnol"},{"issue":"7081","key":"3840_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the nalp3 inflammasome. Nature. 2006;440(7081):237\u201341. https:\/\/doi.org\/10.1038\/nature04516.","journal-title":"Nature"},{"issue":"1","key":"3840_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/annrheumdis-2014-206074","volume":"75","author":"Y Wang","year":"2016","unstructured":"Wang Y, Viollet B, Terkeltaub R, Liu-Bryan R. Amp-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages. Ann Rheum Dis. 2016;75(1):286\u201394. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206074.","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"3840_CR13","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet A, Mosterd A, Eikelboom JW, Schut A, Opstal T, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838\u201347.","journal-title":"N Engl J Med"},{"issue":"26","key":"3840_CR14","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505. https:\/\/doi.org\/10.1056\/NEJMoa1912388.","journal-title":"N Engl J Med"},{"issue":"18","key":"3840_CR15","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/eurheartj\/ehae208","volume":"45","author":"SM Nidorf","year":"2024","unstructured":"Nidorf SM, Ben-Chetrit E, Ridker PM. Low-dose colchicine for atherosclerosis: long-term safety. Eur Heart J. 2024;45(18):1596\u2013601. https:\/\/doi.org\/10.1093\/eurheartj\/ehae208.","journal-title":"Eur Heart J"},{"issue":"1","key":"3840_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.121.056171","volume":"145","author":"SG Deftereos","year":"2022","unstructured":"Deftereos SG, Beerkens FJ, Shah B, Giannopoulos G, Vrachatis DA, Giotaki SG, et al. Colchicine in cardiovascular disease: in-depth review. Circulation. 2022;145(1):61\u201378.","journal-title":"Circulation"},{"issue":"13","key":"3840_CR17","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/heartjnl-2015-309211","volume":"102","author":"DC Tong","year":"2016","unstructured":"Tong DC, Wilson AM, Layland J. Colchicine in cardiovascular disease: an ancient drug with modern tricks. Heart. 2016;102(13):995\u20131002.","journal-title":"Heart"},{"issue":"4","key":"3840_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","volume":"15","author":"S Toldo","year":"2018","unstructured":"Toldo S, Abbate A. The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol. 2018;15(4):203\u201314.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"3840_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-2120-7","volume":"22","author":"S Stewart","year":"2020","unstructured":"Stewart S, Yang K, Atkins K, Dalbeth N, Robinson PC. Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther. 2020;22(1):28. https:\/\/doi.org\/10.1186\/s13075-020-2120-7.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"3840_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41577-019-0167-y","volume":"19","author":"G Lemke","year":"2019","unstructured":"Lemke G. How macrophages deal with death. Nat Rev Immunol. 2019;19(9):539\u201349.","journal-title":"Nat Rev Immunol"},{"key":"3840_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-immunol-042617-053010","volume":"36","author":"S Nagata","year":"2018","unstructured":"Nagata S. Apoptosis and clearance of apoptotic cells. Annu Rev Immunol. 2018;36:489\u2013517.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"3840_CR22","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.cmet.2021.10.015","volume":"33","author":"BD Gerlach","year":"2021","unstructured":"Gerlach BD, Ampomah PB, Yurdagul AJ, Liu C, Lauring MC, Wang X, et al. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 2021;33(12):2445\u201363.","journal-title":"Cell Metab"},{"key":"3840_CR23","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3389\/fimmu.2018.01486","volume":"9","author":"S Caruso","year":"2018","unstructured":"Caruso S, Poon I. Apoptotic cell-derived extracellular vesicles: more than just debris. Front Immunol. 2018;9:1486.","journal-title":"Front Immunol"},{"key":"3840_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.839248","volume":"10","author":"Y Ge","year":"2022","unstructured":"Ge Y, Huang M, Yao YM. Efferocytosis and its role in inflammatory disorders. Front Cell Dev Biol. 2022;10:839248. https:\/\/doi.org\/10.3389\/fcell.2022.839248.","journal-title":"Front Cell Dev Biol"},{"issue":"38","key":"3840_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202402521","volume":"34","author":"M Kang","year":"2024","unstructured":"Kang M, Li Z, Chang I, Xu C, Chiang M, Kim L, et al. Phosphatidylserine-incorporated exosome mimetics encapsulating cxcr3 antagonist alleviate osteoporosis. Adv Funct Mater. 2024;34(38):2402521. https:\/\/doi.org\/10.1002\/adfm.202402521.","journal-title":"Adv Funct Mater"},{"key":"3840_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jconrel.2022.09.045","volume":"351","author":"M Zhou","year":"2022","unstructured":"Zhou M, Li YJ, Tang YC, Hao XY, Xu WJ, Xiang DX, et al. Apoptotic bodies for advanced drug delivery and therapy. J Control Release. 2022;351:394\u2013406. https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.045.","journal-title":"J Control Release"},{"key":"3840_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.actbio.2021.07.002","volume":"131","author":"G Zhang","year":"2021","unstructured":"Zhang G, Xue H, Sun D, Yang S, Tu M, Zeng R. Soft apoptotic-cell-inspired nanoparticles persistently bind to macrophage membranes and promote anti-inflammatory and pro-healing effects. Acta Biomater. 2021;131:452\u201363. https:\/\/doi.org\/10.1016\/j.actbio.2021.07.002.","journal-title":"Acta Biomater"},{"key":"3840_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122483","volume":"306","author":"YD Xu","year":"2024","unstructured":"Xu YD, Liang XC, Li ZP, Wu ZS, Yang J, Jia SZ, et al. Apoptotic body-inspired nanotherapeutics efficiently attenuate osteoarthritis by targeting brd4-regulated synovial macrophage polarization. Biomaterials. 2024;306:122483. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122483.","journal-title":"Biomaterials"},{"issue":"4","key":"3840_CR29","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201469R","volume":"37","author":"N Schwarz","year":"2023","unstructured":"Schwarz N, Fernando S, Chen YC, Salagaras T, Rao SR, Liyanage S, et al. Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation. FASEB J. 2023;37(4):e22846.","journal-title":"FASEB J"},{"issue":"2","key":"3840_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","volume":"93","author":"L Nagy","year":"1998","unstructured":"Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized ldl regulates macrophage gene expression through ligand activation of ppargamma. Cell. 1998;93(2):229\u201340.","journal-title":"Cell"},{"issue":"1","key":"3840_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/CIRCRESAHA.114.302355","volume":"114","author":"C Silvestre-Roig","year":"2014","unstructured":"Silvestre-Roig C, de Winther MP, Weber C, Daemen MJ, Lutgens E, Soehnlein O. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ Res. 2014;114(1):214\u201326. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302355.","journal-title":"Circ Res"},{"key":"3840_CR32","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jconrel.2021.12.021","volume":"341","author":"H Zhou","year":"2022","unstructured":"Zhou H, You P, Liu H, Fan J, Tong C, Yang A, et al. Artemisinin and procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux. J Control Release. 2022;341:828\u201343. https:\/\/doi.org\/10.1016\/j.jconrel.2021.12.021.","journal-title":"J Control Release"},{"issue":"3","key":"3840_CR33","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/01.ATV.0000255581.38523.7c","volume":"27","author":"JK Damas","year":"2007","unstructured":"Damas JK, Smith C, Oie E, Fevang B, Halvorsen B, Waehre T, et al. Enhanced expression of the homeostatic chemokines ccl19 and ccl21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol. 2007;27(3):614\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"3840_CR34","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1161\/CIRCULATIONAHA.110.956730","volume":"122","author":"M Luchtefeld","year":"2010","unstructured":"Luchtefeld M, Grothusen C, Gagalick A, Jagavelu K, Schuett H, Tietge UJ, et al. Chemokine receptor 7 knockout attenuates atherosclerotic plaque development. Circulation. 2010;122(16):1621\u20138.","journal-title":"Circulation"},{"issue":"9","key":"3840_CR35","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/ATVBAHA.113.303081","volume":"34","author":"W Cai","year":"2014","unstructured":"Cai W, Tao J, Zhang X, Tian X, Liu T, Feng X, et al. Contribution of homeostatic chemokines ccl19 and ccl21 and their receptor ccr7 to coronary artery disease. Arterioscler Thromb Vasc Biol. 2014;34(9):1933\u201341. https:\/\/doi.org\/10.1161\/ATVBAHA.113.303081.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3840_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/cvr\/cvu036","volume":"102","author":"B Halvorsen","year":"2014","unstructured":"Halvorsen B, Dahl TB, Smedbakken LM, Singh A, Michelsen AE, Skjelland M, et al. Increased levels of ccr7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells. Cardiovasc Res. 2014;102(1):148\u201356.","journal-title":"Cardiovasc Res"},{"key":"3840_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110431","volume":"121","author":"L Han","year":"2023","unstructured":"Han L, Zhang L. Ccl21\/ccr7 axis as a therapeutic target for autoimmune diseases. Int Immunopharmacol. 2023;121:110431. https:\/\/doi.org\/10.1016\/j.intimp.2023.110431.","journal-title":"Int Immunopharmacol"},{"key":"3840_CR38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fimmu.2020.00528","volume":"11","author":"JL Rodriguez-Fernandez","year":"2020","unstructured":"Rodriguez-Fernandez JL, Criado-Garcia O. The chemokine receptor ccr7 uses distinct signaling modules with biased functionality to regulate dendritic cells. Front Immunol. 2020;11:528.","journal-title":"Front Immunol"},{"key":"3840_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122466","volume":"305","author":"S Li","year":"2024","unstructured":"Li S, Wang K, Jiang K, Xing D, Deng R, Xu Y, et al. Brazilin-ce nanoparticles attenuate inflammation by de\/anti-phosphorylation of ikkbeta. Biomater. 2024;305:122466.","journal-title":"Biomater"},{"key":"3840_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103283","volume":"65","author":"Y Cao","year":"2021","unstructured":"Cao Y, Tang S, Nie X, Zhou Z, Ruan G, Han W, et al. Decreased mir-214-3p activates nf-kappab pathway and aggravates osteoarthritis progression. EBioMedicine. 2021;65:103283.","journal-title":"EBioMedicine"},{"issue":"1","key":"3840_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3840_CR42","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/art.41247","volume":"72","author":"JD Fitzgerald","year":"2020","unstructured":"Fitzgerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 american college of rheumatology guideline for the management of gout. Arthritis Rheumatol. 2020;72(6):879\u201395.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3840_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02228-z","volume":"21","author":"J Tang","year":"2023","unstructured":"Tang J, Li T, Xiong X, Yang Q, Su Z, Zheng M, et al. Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of nf-kappab\/nlrp3 pathways in inflammatory endothelial cells. J Nanobiotechnology. 2023;21(1):460.","journal-title":"J Nanobiotechnology"},{"key":"3840_CR44","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2147\/IJN.S20903","volume":"6","author":"Q Shen","year":"2011","unstructured":"Shen Q, Wang Y, Zhang Y. Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer. Int J Nanomed. 2011;6:1237\u201343.","journal-title":"Int J Nanomed"},{"issue":"3","key":"3840_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40264-022-01265-1","volume":"46","author":"PD Hansten","year":"2023","unstructured":"Hansten PD, Tan MS, Horn JR, Gomez-Lumbreras A, Villa-Zapata L, Boyce RD, et al. Colchicine drug interaction errors and misunderstandings: recommendations for improved evidence-based management. Drug Saf. 2023;46(3):223\u201342. https:\/\/doi.org\/10.1007\/s40264-022-01265-1.","journal-title":"Drug Saf"},{"issue":"5","key":"3840_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/15563650.2010.495348","volume":"48","author":"Y Finkelstein","year":"2010","unstructured":"Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila). 2010;48(5):407\u201314. https:\/\/doi.org\/10.3109\/15563650.2010.495348.","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"3840_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/431592","volume":"41","author":"IF Hung","year":"2005","unstructured":"Hung IF, Wu AK, Cheng VC, Tang BS, To KW, Yeung CK, et al. Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin Infect Dis. 2005;41(3):291\u2013300.","journal-title":"Clin Infect Dis"},{"key":"3840_CR48","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.2147\/DDDT.S140574","volume":"11","author":"S Lev","year":"2017","unstructured":"Lev S, Snyder D, Azran C, Zolotarsky V, Dahan A. Severe hypertriglyceridemia and colchicine intoxication following suicide attempt. Drug Des Devel Ther. 2017;11:3321\u20134.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"3840_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ejhf.1685","volume":"22","author":"SL Harrison","year":"2020","unstructured":"Harrison SL, Lane DA, Lip G. Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes. Eur J Heart Fail. 2020;22(1):136\u20138. https:\/\/doi.org\/10.1002\/ejhf.1685.","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"3840_CR50","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","volume":"142","author":"DC Tong","year":"2020","unstructured":"Tong DC, Quinn S, Nasis A, Hiew C, Roberts-Thomson P, Adams H, et al. Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial. Circulation. 2020;142(20):1890\u2013900.","journal-title":"Circulation"},{"issue":"1","key":"3840_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/6908968","volume":"2024","author":"J Zhang","year":"2024","unstructured":"Zhang J, Pei J, Yu C, Luo J, Hong Y, Hua Y, et al. Ccr7 and cd48 as predicted targets in acute rejection related to m1 macrophage after pediatric kidney transplantation. J Immunol Res. 2024;2024(1):6908968. https:\/\/doi.org\/10.1155\/2024\/6908968.","journal-title":"J Immunol Res"},{"key":"3840_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cytogfr.2020.05.007","volume":"55","author":"K Van Raemdonck","year":"2020","unstructured":"Van Raemdonck K, Umar S, Shahrara S. The pathogenic importance of ccl21 and ccr7 in rheumatoid arthritis. Cytokine Growth Factor Rev. 2020;55:86\u201393.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3840_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.109965","volume":"755","author":"H Yang","year":"2024","unstructured":"Yang H, Liu C, Lin X, Li X, Zeng S, Gong Z, et al. Wogonin inhibits the migration and invasion of fibroblast-like synoviocytes by targeting pi3k\/akt\/nf-kappab pathway in rheumatoid arthritis. Arch Biochem Biophys. 2024;755:109965.","journal-title":"Arch Biochem Biophys"},{"key":"3840_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113922","volume":"156","author":"T Liu","year":"2022","unstructured":"Liu T, Xu M, Shi Z, Li M, Wang R, Shi Y, et al. Shenhuang plaster ameliorates the inflammation of postoperative ileus through inhibiting pi3k\/akt\/nf-kappab pathway. Biomed Pharmacother. 2022;156:113922.","journal-title":"Biomed Pharmacother"},{"key":"3840_CR55","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jare.2024.11.016","volume":"75","author":"T Chu","year":"2025","unstructured":"Chu T, Wang Y, Wang S, Li J, Li Z, Wei Z, et al. Kaempferol regulating macrophage foaming and atherosclerosis through piezo1-mediated mapk\/nf-kappab and nrf2\/ho-1 signaling pathway. J Adv Res. 2025;75:635\u201350.","journal-title":"J Adv Res"},{"key":"3840_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jare.2023.04.007","volume":"57","author":"S Shen","year":"2024","unstructured":"Shen S, Sun T, Ding X, Gu X, Wang Y, Ma X, et al. The exoprotein gbp of fusobacterium nucleatum promotes thp-1 cell lipid deposition by binding to cypa and activating pi3k-akt\/mapk\/nf-kappab pathways. J Adv Res. 2024;57:93\u2013105.","journal-title":"J Adv Res"},{"key":"3840_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100625","volume":"20","author":"X Hao","year":"2023","unstructured":"Hao X, Gan J, Cao J, Zhang D, Liang J, Sun L. Biomimetic liposomes hybrid with erythrocyte membrane modulate dendritic cells to ameliorate systemic lupus erythematosus. Mater Today Bio. 2023;20:100625. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100625.","journal-title":"Mater Today Bio"},{"issue":"8","key":"3840_CR58","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1016\/j.apsb.2023.02.011","volume":"13","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li Z, Huang P, Lin J, Li J, Shi K, et al. Rapidly separating dissolving microneedles with sustained-release colchicine and stabilized uricase for simplified long-term gout management. Acta Pharm Sin B. 2023;13(8):3454\u201370. https:\/\/doi.org\/10.1016\/j.apsb.2023.02.011.","journal-title":"Acta Pharm Sin B"},{"key":"3840_CR59","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jconrel.2023.12.049","volume":"366","author":"EA Kim","year":"2024","unstructured":"Kim EA, Choi HG, Nguyen BL, Oh SJ, Lee SB, Bae SH, et al. Pre-mixing of omega-3 fatty acid-containing liposomes enhances the drug release rate and therapeutic efficacy of anticancer drugs loaded in liposomes. J Control Release. 2024;366:410\u201324. https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.049.","journal-title":"J Control Release"},{"key":"3840_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.resp.2016.06.001","volume":"231","author":"AM Galvao","year":"2016","unstructured":"Galvao AM, Galvao JS, Pereira MA, Cadena PG, Magalhaes NS, Fink JB, et al. Cationic liposomes containing antioxidants reduces pulmonary injury in experimental model of sepsis: liposomes antioxidants reduces pulmonary damage. Respir Physiol Neurobiol. 2016;231:55\u201362.","journal-title":"Respir Physiol Neurobiol"},{"key":"3840_CR61","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jconrel.2023.10.036","volume":"364","author":"H Liu","year":"2023","unstructured":"Liu H, Wang Q, Guo J, Feng K, Ruan Y, Zhang Z, et al. Prodrug-based strategy with a two-in-one liposome for cerenkov-induced photodynamic therapy and chemotherapy. J Control Release. 2023;364:206\u201315. https:\/\/doi.org\/10.1016\/j.jconrel.2023.10.036.","journal-title":"J Control Release"},{"issue":"33","key":"3840_CR62","doi-asserted-by":"publisher","first-page":"8361","DOI":"10.1016\/j.biomaterials.2013.07.042","volume":"34","author":"HH Shen","year":"2013","unstructured":"Shen HH, Lake V, Le Brun AP, James M, Duff AP, Peng Y, et al. Targeted detection of phosphatidylserine in biomimetic membranes and in vitro cell systems using annexin V-containing cubosomes. Biomaterials. 2013;34(33):8361\u20139.","journal-title":"Biomaterials"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03840-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:34:21Z","timestamp":1767054861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3840"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03840-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments was reviewed and approved by the IACUC of Jinan University (Ethical approval number: IACUC-20221116\u201304).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"798"}}